fda drug safety communication semaglutide naion 2025 You've seen the headlines. Should you be worried about medications, like Ozempic, leading to vision loss? Read the full story on Today Show https://ow.ly/zeEX50WBHhz Rybelsus Lawsuit Update May 2026

At 35 degrees Celsius (95 degrees Fahrenheit), the tolerance window shrinks to approximately 4 days

"For the vast majority of patients who are prescribed GLP-1s, they are safe and effective medicines, which deliver significant health benefits," said Alison Cave, the NHRA's safety officer

Key cardiovascular and metabolic conditions include: Hypertension particularly nocturnal hypotension or poorly controlled blood pressure Diabetes mellitus both type 1 and type 2, with microvascular complications Hyperlipidemia contributing to atherosclerotic vascular disease Obstructive sleep apnea causing intermittent hypoxia and hemodynamic fluctuations Coronary artery disease reflecting systemic atherosclerosis Smoking promoting endothelial dysfunction and vascular disease Age represents an independent risk factor, with NAION incidence increasing significantly after 50 years

Remember, Semaglutide GLP-1 is not a weight loss medication per se, but weight loss can be a beneficial side effect for those using it to manage their Type 2 diabetes

Discuss any chronic conditions like diabetes, hypertension, or cardiovascular issues

The service connects patients with licensed healthcare providers who can evaluate their medical needs and prescribe semaglutide for type 2 diabetes management